<%! public String sectionVar = "equity"; public String sectionTitle = "Equity Research"; public String pageVar = "2008 Equity Research"; public String pageTitle = "2008 Equity Research"; %> <%@ include file="/includes/header.jsp" %>

Please see our legal disclaimers within this disclosure section on the web site and/or on the last page of each company review or update. Past research reviews should not be relied upon for any purpose. Research reviews speak only as of the date of the review, and at any time thereafter may no longer be factually accurate and may not reflect our analyst's views on any security.

2008 Reports
		Neurobiological Technologies, Inc. (NTII: NASDAQ) 09.18.08 Defining Outcome Scenarios, Probabilities Appear Focused to the Upside and Future Appreciation

		VioQuest Pharmaceuticals, Inc. (VOQP.OB; NASDAQ) 08.25.08 Creating Value; Turnaround Leverages Product Opportunities while Expectation Abounds and Losses Decrease

		ART Advanced Research Technologies, Inc. (ARA.TO, TSX) 08.18.08 The Way Forward; Investment Validates Lack of Optix^TM Sales and Share Price in a Changing World

		Generex Biotechnology Corp. (GNBT; NASDAQ) 07.30.08 RapidMist^TM the Non-Invasive Oral Drug Delivery Platform, Sets the Tone as Best in Class Followed by an Expanding Pipeline and Global Revenues.

		VioQuest Pharmaceuticals, Inc. (VOQP.OB; NASDAQ) 07.29.08 510k Application Submitted for Xyfid^TM and Priority Review Voucher for Lenocta^TM Focuses Milestones and Share Price Appreciation.

		Advaxis, Inc. (ADXS.OB; NASDAQ) 07.15.08 The New Generation of Cancer Immunotherapeutics.

		VioQuest Pharmaceuticals, Inc. (VOQP.OB; NASDAQ) 06.16.08 Robust Pipeline of Niche’ Cancer Therapies with Billion Dollar Upside.

		ART Advanced Research Technologies, Inc. (ARA.TO, TSX) 05.20.08 Getting Past a Year of Transformation.

		Neurobiological Technologies, Inc. (NTII: NASDAQ) 05.15.08 It’s all about Viprinex; Interim Results are Due in First Half of FY09 for Realization of Greater Shareholder Value.

		ART Advanced Research Technologies, Inc. (ARA.TO, TSX) 03.30.08 Shaking the Tree; Sales Growth Continues Accentuating Gross Margins While Efficiencies Reform the Burn Rate.

		Neurobiological Technologies, Inc. (NTII: NASDAQ) 02.13.08 When You Review Stroke Treatments, Look at One Stroke Drug at a Time; Each One Is Different.

<%@ include file="/includes/footer.jsp" %>